Aldeyra Therapeutics is a biotechnology company engaged in developing and commercializing medicines for patients with immune-mediated diseases. The company's primary product candidate, reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. The company has additional product candidates in development for proliferative vitreoretinopathy and other retinal diseases, autoimmune disease, and cancer. The company has discovered and are developing two additional reactive aldehyde species inhibitors, ADX-103 and ADX-629, for the treatment of retinal disease and autoimmune disease, respectively.

Earthstone Energy is an independent oil and gas company engaged in the acquisition and development of oil and gas reserves through activities that include the acquisition, drilling and development of undeveloped leases, asset and corporate acquisitions and mergers. The company's operations are all in the upstream segment of the oil and natural gas industry and all the company's properties are onshore in the U.S. The company's primary assets are located in the Midland Basin of west Texas and the Eagle Ford Trend of south Texas.

TrueCar is an internet-based information, technology, and communication services company. The company helps consumers by providing information related to what others have paid for a make, model and trim of car in their area and guaranteed savings off the manufacturer's suggested retail price for that make, model and trim, as well as, in instances, price offers on actual vehicle inventory, which it refers to as Vehicle Identification Number-based offers, from its network of TrueCar Certified Dealers. The company's network of TrueCar Certified Dealers consisted mainly of new car franchises, representing various makes of cars, as well as independent dealers selling used vehicles.